Federico Nasroulah, MD
About Federico Nasroulah, MD
Federico Nasroulah, MD, is the Clinical Development Lead for Bladder Cancer at Bristol Myers Squibb in San Francisco, California, with over 20 years of experience in oncology and internal medicine.
Title
Federico Nasroulah, MD, is the Clinical Development Lead for Bladder Cancer at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Federico is currently based in San Francisco, California, United States, where he serves as the Clinical Development Lead focusing on bladder cancer at Bristol Myers Squibb. In this role, he is responsible for overseeing clinical trials and development programs aimed at advancing treatment options for bladder cancer patients.
Previous Positions
Before his current role, Federico held various significant positions in the field of oncology. Between 2020 and 2021, he was the Clinical Science Lead for Prostate Cancer at Genentech, based in South San Francisco, California. He also worked as Senior Medical Director at Genentech from 2018 to 2020. Federico served as Associate Vice President at Eli Lilly and Company from 2014 to 2018 in New York and surrounding areas. Before this, he was Senior Medical Director at ImClone Systems, a subsidiary of Eli Lilly and Company, from 2012 to 2014.
Early Career
Federico started his career as an Internal Medicine Resident at Hospital de Clínicas 'José de San Martín' from 2000 to 2003. He then progressed to an Oncology Fellow at Instituto Alexander Fleming from 2003 to 2006. Following this, he worked as a Staff Physician in the medical oncology department at Sanatorio Güemes from 2006 to 2011. From 2008 to 2011, he served as the Oncology Regional Medical Advisor for the Latin America and Caribbean region at Eli Lilly.
Education and Certifications
Federico earned his MD from the University of Buenos Aires, where he studied Medicine from 1994 to 2000. He holds board certifications in Internal Medicine and Clinical Oncology, underscoring his extensive expertise in these domains.
Areas of Expertise
Federico specializes in Genitourinary and Gastrointestinal oncology. He has extensive experience in protocol development and clinical research in oncology, as well as statistical analysis. His work includes developing marketing and scientific strategies for data dissemination and supporting marketing plans in oncology.
Research and Regulatory Experience
Federico has led late phase (phase II and III) clinical development programs and managed submissions for registration to global regulatory agencies such as the FDA, EMA, and PMDA. His published work in major oncology journals reflects his contribution to the field. Additionally, he has experience in global medical affairs, serving as the global CRC medical lead for three years.